Virpax Reports on Progress of Envelta™

BERWYN, Pa.–(BUSINESS WIRE)– #pharma–Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and viral barrier indications, today announced recent progress made in its Envelta development program. Envelta is the Company’s non-opioid pain ... Read More

Global Gastrointestinal Agents Industry Report to 2030: North America Dominates the Market – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Gastrointestinal Agents Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030” report has been added to ResearchAndMarkets.com’s offering. The report offers strategic insights into the overall gastrointestinal agents market along with the market size and estimates for the ... Read More